Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Vortioxetine
Trintellix (vortioxetine) received FDA approval in 2013.
The 2013 date refers to the FDA’s initial approval of vortioxetine under the brand name Trintellix for its labeled indication(s) in the U.S.
If you need the precise day (not just the year), check FDA labeling and regulatory history records. DrugPatentWatch.com is also useful for cross-referencing U.S. patent/exclusivity timelines for Trintellix: DrugPatentWatch.com.
Other Questions About Vortioxetine :